Last reviewed · How we verify
NCT07444242: AcctDCS
Accelerated Treatment of Depressive Patients With tDCS
NA trial testing Transcranial direct current stimulation in Major Depressive Disorder in 30 participants. Not yet recruiting.
30 November 2026
Quick facts
| Lead sponsor | University of Regensburg |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 16 March 2026 |
| Primary completion | 30 November 2026 |
| Estimated completion | 31 December 2026 |
Drugs / interventions tested
- Transcranial direct current stimulation
Conditions studied
- Major Depressive Disorder — all drugs for Major Depressive Disorder →
Sponsor
University of Regensburg
Who can join
Adults 18 to 70, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized, controlled three-arm study is planned to investigate the effectiveness and feasibility of an accelerated home-based tDCS application (3 weeks of transcranial direct current stimulation at home, twice daily). A total of 30 patients with depression (10 per group), who are currently not taking and have no history of taking antidepressant medication, will be randomly assigned to either an active tDCS condition, a sham (placebo) tDCS condition, or a waitlist control group. The latter two groups will receive active tDCS treatment after completion of the control phase. This study represents a continuation of the pilot study GSUND DAHOAM (Ethics approval: 20-2091-101; Dragon et al., 2024).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07444242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcranial direct current stimulation
Trials testing the same drug.
- NCT07433972 — Changes in Hemodynamic Response Following Transcranial Electrical Stimulation in Sroke Individuals · NA · not yet recruiting
- NCT07257601 — TDCS-RTMS Intervention for Motor Function · NA · not yet recruiting
- NCT06501820 — Neural Control of Gait & Navigation in ADRD · NA · enrolling by invitation
- NCT06976697 — Home-Based tDCS Treatment Of Major Depressive Disorder · NA · recruiting
- NCT06888700 — Project on tDCS Intervention to Enhance Advanced Social Cognitive Functions in Drug Rehabilitation Individuals · NA · enrolling by invitation
Other recruiting trials for Major Depressive Disorder
Currently open trials in the same condition.
- NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
- NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
- NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting
Other University of Regensburg trials
Trials by the same sponsor.
- NCT06766214 — Attexis and tDCS for the Treatment of ADHD · NA · completed
- NCT06689592 — Mobile Transcranial Magnetic Stimulation · NA · completed
- NCT06520865 — TIDE Project: Biomarker Discovery for Chronic Tinnitus Diagnosis · completed
- NCT06212895 — Expectations of Patients Regarding Exercise in an Outpatient Clinic · unknown
- NCT05791812 — Application of Direct Current Transcranial stImulation, Remotely superVised in Chronic fATiguE · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07444242 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Regensburg
- Last refreshed: 2 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07444242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing